EMDLP

EMDLP identifies RNA methylation sites using natural language processing and a multiscale deep learning architecture that combines dilated convolutional neural networks and Bidirectional LSTM to predict m1A and m6A modification positions.

Key Features:

• Sequence representation: Uses NLP-based encodings including RNA word embedding, One-hot encoding, and RGloVe to represent RNA sequences.
• Model architecture: Employs a Dilated Convolutional Bidirectional LSTM (DCB) network integrating dilated convolutional neural networks (DCNNs) with BiLSTM layers.
• Multiscale feature extraction: Captures local and global sequence context via dilated convolutions for local responses and BiLSTM for sequential context.
• Ensemble integration: Combines predictions from different encodings/models using a soft voting mechanism.
• Performance metrics: Reports AUROC scores of 95.56% for m1A and 85.24% for m6A, surpassing existing state-of-the-art models.

Scientific Applications:

• m1A site prediction: Predicts m1A methylation sites in RNA sequences.
• m6A site prediction: Predicts m6A methylation sites in RNA sequences.
• Epi-transcriptome studies: Facilitates investigation of RNA modifications involved in post-transcriptional regulation.
• Method comparison and benchmarking: Enables evaluation of predictive performance against other models using AUROC.

Methodology:

EMDLP represents RNA sequences with RNA word embedding, One-hot encoding, and RGloVe; inputs these encodings into a Dilated Convolutional Bidirectional LSTM (DCB) network combining DCNNs and BiLSTM; and integrates model outputs via a soft voting mechanism.